Clinical Trial

Phase 1 Clinical Study of GenSci155 Injection in Healthy Adults

Name: Phase 1 Clinical Study of GenSci155 Injection in Healthy Adults — clinical trial record (NCT07638800)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a Phase 1, single-center, randomized, double-blind, placebo-controlled, single and multiple intravenous ascending dose clinical study to evaluate the safety, tolerability, PK, immunogenicity, and biomarker characteristics of GenSci155 after a single or multiple intravenous injection in healthy Chinese adult trial participants.

Trial Details

NCT Number	NCT07638800
Lead Sponsor	Changchun GeneScience Pharmaceutical Co., Ltd.
Conditions	Healthy Adult Trial Participants
Enrollment	68 participants
Start Date	2026-07-28
Primary Completion	2027-04-16 (estimated)
Study Completion	2027-07-28 (estimated)
Updated on ClinicalTrials.gov	2026-06-10